FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.
You may also be interested in...
FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.
Nanotech Growth Means Shrinking Window For Enacting Effective Regulation
Ground rules on regulating the use of nanoscale materials in dietary supplements and other consumer products are urgently needed with the nascent technology exploding in the marketplace, a former FDA executive says
FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner
The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice